BGBx published a new white paper titled The Execution Gap examining the forces making it harder to turn commercial ambition into impact.
Public source
Publisher name
Public post
Pharma brand teams aren't short on ambition. So why is commercial execution getting harder? Drawing on research across 800 pharma brand leaders, our new white paper, "Th…
Company
BGBx
- Industry
- Advertising Services
- Location
- New York, US
- Company size
- 501–1,000 employees
About BGBx
BGBx is an independent commercial solutions partner for pharmaceutical and life science companies and their brands, combining consulting, communications, science, creativity, data, technology, innovation, and digital capabilities to deliver breakthrough results. Through BGBx Consulting and BGBx Communications, the company helps clients set strategy early, stay aligned throughout the product lifecycle, and execute through marketing and communications programs that drive impact. BGBx is Built for Breakthrough.
See moreLatest activity
Latest activity from BGBx
7 signals
Research & Knowledge
BGBx published a white paper developed alongside ESC Congress 2026 on CKM syndrome, cardiovascular-kidney-metabolic syndrome, and the joint guideline that now stages it, measures it, and treats it as a single continuum.
Research & Knowledge
BGBx published a white paper co-authored by Geoff Catalano, PhD, Samema Sarowar, PhD, and Amanda Eckel on the clinical challenges and referral pathways for CKM syndrome, cardiovascular-kidney-metabolic syndrome, and cross-specialty coordination.
Research & Knowledge
BGBx conducted research across 800 pharma brand leaders to explore the friction in brand execution.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Xavier Creative House (XCH)
Xavier Creative House (XCH) published a new piece titled 'Payer Marketing in the 2027 Brand Plan' analyzing how payer strategy fits into the 2027 brand plan and the value story belonging to brand, medical, and market access together.
Research & Knowledge
Digital Remedy
Digital Remedy published a new white paper breaking down what's real, what's rebranded, and what to ask before taking anyone's word for it.
Research & Knowledge
Pharma D-mand
Pharma D-mand published a new Industry Intelligence for Life Sciences exploring how pharma leaders are reshaping strategy around execution.
Research & Knowledge
Syneos Health Communications
Syneos Health Communications published the Ticket to Biotech AI in Biopharma Communications Survey, which highlights that only a quarter of pharma communicators are leaning about AI through internal training.
Research & Knowledge
Throtle